KLF4 has been found to act as a tumor suppressor in GC progression, such as, MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4 and inhibits KLF4 expression in GC cells [13]. This evidence concerns the gene KLF4 and gastric carcinoma.